Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

CONCLUSIONS: This meta-analysis suggested that PAI-1 4G/5G polymorphism was a risk factor for CAD. PMID: 25419432 [PubMed - as supplied by publisher]
Source: International Journal of Clinical and Experimental Medicine - Category: Drugs & Pharmacology Tags: Int J Clin Exp Med Source Type: research